Related Experiment Videos
Central nervous system tumors in children
1Division of Pediatric Neuro-Oncology, Duke University Medical Center, Durham, NC 27710, USA.
Seminars in Oncology Nursing
|March 21, 1998
Summary
Pediatric central nervous system (CNS) tumors present unique challenges compared to adult tumors. A family-centered nursing approach is crucial for managing the impact of childhood brain tumors and monitoring for long-term effects.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Childhood Cancer Research
Background:
- Central nervous system (CNS) tumors are a significant concern in both pediatric and adult populations.
- Understanding the distinct characteristics of pediatric CNS tumors is essential for effective management.
- Children possess unique physiological and developmental factors that influence tumor presentation and treatment response.
Purpose of the Study:
- To delineate the differences between pediatric and adult central nervous system (CNS) tumors.
- To explore the specific diagnostic and therapeutic considerations for pediatric brain tumors.
- To discuss the long-term sequelae associated with childhood CNS tumors.
Main Methods:
- Comprehensive literature review.
- Analysis of existing research articles, book chapters, and abstracts.
- Synthesis of data on pediatric and adult CNS tumor characteristics.
Main Results:
- Pediatric CNS tumors exhibit distinct biological behaviors and clinical presentations compared to their adult counterparts.
- Treatment modalities for pediatric brain tumors carry a higher risk of permanent damage due to the developing nature of a child's body and brain.
- Long-term effects, including intellectual and endocrinologic deficits, require vigilant monitoring.
Conclusions:
- Children with CNS tumors have specific needs throughout their treatment journey and survivorship.
- A family-centered nursing approach is vital for supporting children and their families in coping with the challenges of a brain tumor diagnosis.
- Oncology nurses must be well-informed to monitor for and manage intellectual, endocrinologic, and oncogenic late effects in pediatric patients.